Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEG-Guided Plasma Exchange for HBV-ACLF
NCT04747106Unknown
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Jul 2020
- Primary completion
- Apr 2021
- Countries
- 1
01
Overview
Randomised, open-label trial in acute-on-chronic liver failure (ACLF) (2 arms), sponsored by Nanfang Hospital, Southern Medical University. Primary endpoint: 28-day mortality. Status: unknown.
02
Conditions
acute-on-chronic liver failure (ACLF)
Beyond the preview
Go deeper on NCT04747106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04747106.